Planning our Growth
Construction of our West Coast manufacturing facility in Rancho Cucamonga, CA is progressing quickly. The new 230,000 sq ft plant will be ISO 13485 certified, cGMP compliant, and FDA registered and will house dedicated ISO Class 8 molding and assembly cleanrooms, Injection molding, Injection Blow Molding, and Injection Stretch Blow Molding, to support the medical device and consumer healthcare markets. The facility will feature a full-service design and development lab, incorporating dedicated mold sampling, rapid prototyping equipment to enable Comar to rapidly bring you from ideation, to design, to prototype, through to full production.
Supporting your Demand
Comar continues to add capabilities and investments to better serve existing and potential customers. The new cleanrooms are designed to incorporate both molding (including 2-shot) and assembly of devices and sub-assemblies for the medical, diagnostic, and drug delivery markets. Additional capabilities will include “Design for Manufacturing” services, in-house mold making and prototyping, automated assembly, injection molding (insert, over, and two shot), and blow molding.
Phase 1 Site Construction
Phase 2 Site Construction
June 5, 2024
Comar Celebrates 75 Years of InnovationComar proudly announces its 75th anniversary as a leading contract manufacturer for healthcare companies worldwide and as a leading provider of primary packaging and dispensing products. Founded on the guiding principles of excellence, dedication, and customer-centricity, Comar has established itself as a trusted partner for clients in the Medical, Pharmaceutical, Consumer Healthcare, Personal & Home
May 28, 2024
Comar Achieves CE Certification for Medical Devices Under New EU MDR RegulationsComar, a leading provider of innovative medical devices and packaging solutions, is thrilled to announce a significant achievement. After rigorous preparation, they successfully obtained their CE certificate under the latest EU Medical Device Regulations (EU MDR 2017/745). This certification is a significant milestone, marking Comar’s compliance with the latest European Union medical device standards. The
September 28, 2022
Comar Announces Brian Larkin as President and Chief Executive OfficerComar has named Brian Larkin as its new President and Chief Executive Officer, succeeding Mike Ruggieri, who will transition to the Chairman role and remain on the Board of Directors. Under Mr. Ruggieri’s 15 years of leadership, Comar evolved from a single site family-owned business to a professionally backed, multi-national company with expanded customer relationships,
